All Type of News
Drugmakers struggling to replace asbestos -free drugs
The Korea Food and Drug Administration said on April 21 that a total of 227 medicinal products, which were confirmed to have used talc contaminated with asbestos and banned from sale, were replaced by new supplies as ...
Bukwang stops marketing of clevudine tentatively
Bukwang Pharm said it has voluntarily halted the marketing of Levovir (clevudine) for the treatment of chronic hepatitis B (HBV) infection as its US partner Pharmasset, Inc. decided to voluntarily terminate Phase III ...
Bayer HealthCare opens Web site for vitamin C preparation
Bayer Healthcare has recently launched its Web site (www.redoxon.co.kr) for Redoxon Double Action chewable vitamin C & Zinc tablets.
This Website is aimed at providing housewives with the human’s immune system in m...
LG Life Sciences to release new sustained-release formulations of human growth hormone
LG Life Sciences (LGLS) is expected to launch its home-grown sustained-release preparation of human growth hormone for treatment of SGA (small for gestational age) in Korea under the trade name Eutropine Plus.
Infa...
KFDA to separate surveillance and disposition functions over drug and medical device
The Korea Food and Drug Administration is aiming to streamline operations and boost efficiency of its six regional agencies by separating the surveillance and disposition functions over drugs and medical device, if th...
KFDA lifts sales ban over 32 drugs
The Korea Food and Drug Administration said on April 17 that it has withdrawn the sales ban of 32 medicinal products which were found not to contain asbestos after investigating 307 drugs produced by 54 pharmaceutical...
624 drugs delisted from health insurance
A total of 624 drugs are still put on the list of sale banned products as they were confirmed to have used talc contaminated with asbestos, according to the Health Insurance Review and Assessment Service.
It said 3...
Novel oral cholera vaccine approved in India
A new low-cost oral cholera vaccine, which was jointly developed by the International Vaccine Institute (IVI) and Vietnamese manufacturer VaBiotech, has been licensed in India.
The vaccine could soon be made availa...
Korea Bone Bank takes over Endotec for $20 million
Korea Bone Bank Inc (KBBI), the local largest processor of allograft bones and connective tissues for transplantation, said on April 20 that it acquired a controlling stake in the US based Endotec Inc., after a succes...
KFDA looks into drug makers
The Korea Food and Drug Administration has embarked on looking into 120 pharmaceutical manufacturers who distributed medicinal products containing talc contaminated with carcinogenic asbestos.
Since some baby powde...
